RESÚMENES FEBRERO 2006

.

Addictive Disorders

(Haga un click en la información del journal para acceder al resúmen)

 

Multicenter Investigation of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling

Jon E. Grant, Marc N. Potenza, Eric Hollander, Renee Cunningham-Williams, Tommi Nurminen, Gerard Smits, and Antero Kallio

Am J Psychiatry 163:303-312, February 2006

 

Outcomes of Bupropion Therapy for Smoking Cessation During Routine Clinical Use

Elan C Paluck, James P McCormack, Mary HH Ensom, Marc Levine, Judith A Soon, David W Fielding

The Annals of Pharmacotherapy: Vol. 40, No. 2, pp. 185-190

 

Injectable, Sustained-Release Naltrexone for the Treatment of Opioid Dependence. A Randomized, Placebo-Controlled Trial

Sandra D. Comer, Maria A. Sullivan, Elmer Yu, Jami L. Rothenberg, Herbert D. Kleber, Kyle Kampman, Charles Dackis, Charles P. O’Brien

Arch Gen Psychiatry. 2006;63:210-218

 

Risk factors for experiencing psychosis during cocaine use: A preliminary report

Alicia G. Floyd, Nashaat N. Boutros, Frederick A. Struve, Elizabeth Wolf and Glen M. Oliwa

Journal of Psychiatric Research. Volume 40, Issue 2, March 2006, Pages 178-182

 

Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence
Soyka M, Schmidt F, Schmidt P

Pharmacopsychiatry. 2006 Jan;39(1):30-4

 

Lifetime Comorbidity of DSM-IV Mood and Anxiety Disorders and Specific Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Kevin P. Conway, Wilson Compton, Frederick S. Stinson, and Bridget F. Grant

J Clin Psychiatry 2006;67:247-257

 

Nicotine and nonnicotine factors in cigarette addiction

Jed E. Rose

Psychopharmacology 2006; Volume 184, Numbers 3-4: 274 - 285

 

Nicotinic modulation of neuronal networks: from receptors to cognition

Huibert D. Mansvelder, Karlijn I. van Aerde, Jonathan J. Couey and Arjen B. Brussaard

Psychopharmacology 200; Volume 184, Numbers 3-4: 292 - 305

 

Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement

Nadia Chaudhri, Anthony R. Caggiula, Eric C. Donny, Matthew I. Palmatier, Xiu Liu and Alan F. Sved

Psychopharmacology 2006; Volume 184, Numbers 3-4: 353 - 366

 

Nicotine as a typical drug of abuse in experimental animals and humans

Bernard Le Foll and Steven R. Goldberg

Psychopharmacology 2006;  Volume 184, Numbers 3-4: 367 - 381

 

Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition

Liliana Spina, Sandro Fenu, Rosanna Longoni, Emilia Rivas and Gaetano Di Chiara

Psychopharmacology 2006;  Volume 184, Numbers 3-4: 447 - 455

 

Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization

Edward D. Levin, F. Joseph McClernon and Amir H. Rezvani

Psychopharmacology 2006; Volume 184, Numbers 3-4: 523 - 539

 

Human nicotine conditioning requires explicit contingency knowledge: is addictive behaviour cognitively mediated?

Lee Hogarth and Theodora Duka 

Psychopharmacology 2006;  Volume 184, Numbers 3-4: 553 - 566

 

Nicotine psychobiology: how chronic-dose prospective studies can illuminate some of the theoretical issues from acute-dose research

Andrew C. Parrott 

Psychopharmacology 2006;  Volume 184, Numbers 3-4: 567 - 576

 

A behavioural and functional neuroimaging investigation into the effects of nicotine on sensorimotor gating in healthy subjects and persons with schizophrenia

Peggy Postma, Jeffrey A. Gray, Tonmoy Sharma, Mark Geyer, Ravi Mehrotra, Mrigen Das, Elizabeth Zachariah, Melissa Hines, Steven C. R. Williams and Veena Kumari 

Psychopharmacology 2006;  Volume 184, Numbers 3-4: 589 - 599

 

Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking

Kenneth A. Perkins, Todd Doyle, Melinda Ciccocioppo, Cynthia Conklin, Michael Sayette and Anthony Caggiula

Psychopharmacology 2006; Volume 184, Numbers 3-4: 600 - 607

 

Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy

Saul Shiffman, Stuart G. Ferguson, Chad J. Gwaltney, Mark H. Balabanis and William G. Shadel

Psychopharmacology 2006; Volume 184, Numbers 3-4: 637 - 644

 

Role of Noradrenergic Signaling by the Nucleus Tractus Solitarius in Mediating Opiate Reward

Valerie G. Olson, Carrie L. Heusner, Ross J. Bland, Matthew J. During, David Weinshenker, Richard D. Palmiter

Science 17 February 2006: Vol. 311. no. 5763, pp. 1017 - 1020

Baclofen in the Treatment of Alcohol Withdrawal Syndrome: A Comparative Study vs Diazepam

Giovanni Addolorato, Lorenzo Leggio, Ludovico Abenavoli, Roberta Agabio, Fabio Caputo, Esmeralda Capristo, Giancarlo Colombo, Gian Luigi Gessa and Giovanni Gasbarrini

The American Journal of Medicine. Volume 119, Issue 3, March 2006, Pages 276.e13-276.e18

 

Association of personality disorders with Type A and Type B alcoholics

M. Bottlender, U. W. Preuss and M. Soyka

European Archives of Psychiatry and Clinical Neuroscience 2006; Volume 256, Number 1: 55 - 61

 

Effects of monoamine oxidase inhibitors on cocaine discrimination in rats
Gatch, Michael B; Taylor, Cynthia M; Flores, Elva; Selvig, Meghan; Forster, Michael J

Behavioural Pharmacology. 17(2):151-159, March 2006

Alcohol use disorders in relatives of patients with panic disorder

Renee D. Goodwin, Joshua D. Lipsitz, Tim F. Chapman, Salvatore Mannuzza, Donald F. Klein, Abby J. Fyer

Comprehensive Psychiatry. Volume 47, Issue 2, Pages 88-90 (March 2006)

.

Regresar a RESÚMENES FEBRERO 2006